Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes.

Beer, Tomasz M

Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes. [electronic resource] - Clinical genitourinary cancer Sep 2008 - 103-9 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

1558-7673

10.3816/CGC.2008.n.016 doi


Aged
Aged, 80 and over
Benzamides--blood
Disease-Free Survival
Drug Evaluation
Drug Resistance, Neoplasm
Humans
Kinesins--antagonists & inhibitors
Male
Middle Aged
Prostate-Specific Antigen--analysis
Prostatic Neoplasms--drug therapy
Quinazolines--blood
Taxoids--therapeutic use